nanopathdx has developed a testing platform that can detect multiple viral RNA targets directly from a nasal swab within minutes instead of hours. The platform is composed of a disposable test cartridge for patient sample processing and a portable sample processing and readout machine. The technology was developed to identify pathogens in the body and is being deployed to detect SARS-CoV-2 specifically.